Medical Cannabis Market UK Worth £150m in 2025
Industry analysis suggests the UK legal medical cannabis market reached approximately £150 million in total retail value during 2025, with strong growth projections for the coming years.
The UK legal medical cannabis market reached an estimated retail value of approximately £150 million during 2025, according to analysis compiled from licensed clinic prescription volumes, pharmacy dispensing data, and import licence records. The figure represents growth of around 60% compared to the estimated market size two years earlier.
Market Composition
Whole-flower cannabis products for vaporisation remain the largest segment by volume, accounting for roughly 45% of total prescription value. Oil-based formulations represent approximately 35%, with the remaining 20% split between capsules, oral sprays, and pharmaceutical-grade cannabidiol preparations.
Growth Drivers
- Rapid growth in the number of registered specialist prescribers and licensed clinics
- Increasing awareness among healthcare professionals of referral pathways
- Patient community advocacy and improved media coverage raising public awareness
- Competitive pricing as the market has matured and import volumes have grown
Forecast
Industry analysts project the UK market could reach £280 to £320 million in retail value by 2027, assuming continued policy stability and incremental expansion of eligible prescribing indications. A significant acceleration could occur if any major NHS integrated care board moves towards systematic CBMP prescribing for chronic pain.
"The UK market is now large enough to attract serious institutional investment. We are moving from early-adopter territory into genuine mainstream healthcare provision."
